País: Regne Unit
Idioma: anglès
Font: MHRA (Medicines & Healthcare Products Regulatory Agency)
Sulfur; Charcoal medicinal vegetable; Rhubarb extract; Senna leaf powdered
Reckitt Benckiser Healthcare (UK) Ltd
n/a
Sulfur; Charcoal medicinal vegetable; Rhubarb extract; Senna leaf powdered
50mg ; 180mg ; 25mg ; 105mg
Oral tablet
Oral
No Controlled Drug Status
Never Valid To Prescribe As A VMP
BNF: 01060200; GTIN: 5000158067769
_PACKAGE LEAFLET: INFORMATION FOR THE USER _ _ _ SENOKOT COMFORT TABLETS SENNA LEAF RHUBARB ROOT EXTRACT VEGETABLE CHARCOAL PURIFIED SULPHUR READ ALL OF THIS LEAFLET CAREFULLY BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. This medicine is available without prescription. However, you still need to take Senokot Comfort Tablets carefully to get the best results from it. • Keep this leaflet. You may need to read it again. • Ask your pharmacist if you need more information or advice. • You must contact a doctor if your symptoms worsen, or do not improve after a few days. • If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. IN THIS LEAFLET: 1. What Senokot Comfort Tablets are and what they are used for. 2. Before you take Senokot Comfort Tablets. 3. How to take Senokot Comfort Tablets 4. Possible side effects. 5. How to store Senokot Comfort Tablets 6. Further information. _ _ _1. WHAT SENOKOT COMFORT TABLETS ARE AND WHAT THEY ARE USED FOR _ Senokot Comfort Tablets are used for the short-term relief of occasional constipation Senokot Comfort Tablets do not help with weight loss. The laxative effect of Senokot Comfort Tablets takes place approximately 8-12 hours after taking the product. _ _ _2. BEFORE YOU TAKE SENOKOT COMFORT TABLETS _ DO NOT TAKE SENOKOT COMFORT TABLETS • if you are allergic (hypersensitive) to Senna leaf, Rhubarb , vegetable charcoal, purified sulphur or any other ingredients of Senokot Comfort Tablets. • If you have blockage or narrowing of the gastro-intestinal tract or bowel (ileus, intestinal obstruction or stenosis) • If you have paralysis or lack of muscle tone in the bowel (atony) • If you have appendicitis, inflammatory bowel disease such as Crohn’s disease or ulcerative colitis • If you have severe dehydration • If you have persistent or undiagnosed abdominal complaints e.g. pain, nausea or vomiting • If you have faecal impaction or rectal bleeding for which you don’t kno Llegiu el document complet
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Eucarbon Tablets Senokot Comfort Tablets_ _ 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains: 105 mg of Senna leaf (_Cassia senna_ L. (_C. acutifolia _Delile) and/or _Cassia _ _angustifolia _Vahl), 25 mg of extract (as dry extract) from Rhubarb root (_Rheum palmatum _L. or _Rheum officinale _Baillon, or hybrids of these two species or a mixture) (3 5: 1)Extraction solvent : Ethanol 70% v/v Corresponding to 2,65-3,95 mg of hydroxyanthracene glycosides (calculated as Rhein), 180 mg of Vegetable Charcoal. 50 mg of purified Sulfur Excipient(s) with known effect: Each tablet contains 43.4 mg of sucrose and 0.25 – 11.25 mg of lactose monohydrate. For the full list of excipients, see section 6. 3 PHARMACEUTICAL FORM Tablets for oral administration. Grey-black, cylindric, biconvex tablets. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS The product is a traditional remedy for short-term use in cases of occasional constipation. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION POSOLOGY _Adolescents over 12 years of age, adults, elderly_ 1-2 tablets with or after meals with liquid up to 3 times daily to obtain a laxative and purgative effect. If a stronger laxative effect is desired, the evening dose can be increased to 3 – 4 tablets of the product. Herbal substance/preparation corresponding to 2.65 to 3.95 mg of hydroxyanthracene glycosides (calculated as Rhein) in one tablet. The maximum daily dose of hydroxyanthracene glycosides is 30 mg. This is equivalent to 8 tablets. The correct individual dose is the smallest required to produce a comfortable soft-formed motion. _Paediatric population_ The use in children under 12 years of age is contraindicated (see section 4.3 Contraindications). METHOD OF ADMINISTRATION For oral use. DURATION OF USE Use for more than 1 - 2 weeks requires medical supervision. If the symptoms persist during the use of the medicinal product, a doctor or a pharmacist should be consulted. See also section 4.4 Special war Llegiu el document complet